Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to the Antibody Drug Conjugate Sacituzumab Govitecan

AFFECTION_STATUS - Case control status of subject for metastatic TNBC (phv00494802.v1.p1)
ANALYTE_TYPE - Analyte Type (phv00494807.v1.p1)
BODY_SITE - Body site where sample was collected (phv00494806.v1.p1)
CONSENT - Consent (phv00494797.v1.p1)
IS_TUMOR - Tumor status (phv00494808.v1.p1)
MANUSCRIPT_LESION_ID - Lesion ID in Manuscript 10.1158/2159-8290.CD-21-0702 (phv00494809.v1.p1)
SAMPLE_ID - Sample ID (phv00494805.v1.p1)
SAMPLE_ID - Sample ID (phv00494800.v1.p1)
SUBJECT_ID - Subject ID (phv00494801.v1.p1)
SUBJECT_ID - Subject ID (phv00494796.v1.p1)
SUBJECT_ID - Subject ID (phv00494799.v1.p1)